Acute Myeloid Leukemia
Lisofylline Results Reported Among Patients with Newly Diagnosed Cancer
Published in Cancer Weekly, July 28th, 1997
Cell Therapeutics, Inc., Seattle, Washington, announced preliminary results from a Phase II trial of its lead drug candidate, lisofylline (LSF), among patients with newly diagnosed acute myeloid leukemia.
The randomized, double-blind, placebo-controlled trial of the Cell Therapeutic Inc. (Seattle, Washington) product was conducted at the University of Texas M.D. Anderson Cancer Center, Houston, Texas, under direction of principal investigator Elihu Estey, M.D.
In this trial, 70 patients, ages 19 to 70 years,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1997-07-28)
More Articles from Cancer Weekly
- Tumor Immunotherapy
Linking Improves Antitumor Effect of MAbs - Breast Cancer
Evaluation Completed of 'Deep Focused Heat' Cancer Treatment System - Breast Cancer (Screening)
CT Laser System May Become Test of Choice for Women for Early Cancer Detection - Cancer Therapy
Phase I Results with Onyx-015 Updated - Cancer Therapy
Thermochemotherapy Hemi-Perfusion Trial Begins - Cervical Cancer
Study Finds HRT Does Not Increase Cancer Risk - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
